rituximab
CDR0000269136
Phase 2 mab completed
Quick answer
rituximab for Lymphoma is a Phase 2 program (mab) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Lymphoma
- Phase
- Phase 2
- Modality
- mab
- Status
- completed